PTPRC and Miyoshi myopathy: Similarly to previous reports showing that MβCD treatment did not modulate the expression of surface receptors, such as B Cell Receptor, CD4 or CXCR4 [41], [42], we showed that MβCD treatment did not modulate the expression levels of CXCR4 or CD45 on the surface of MM cells (data not shown).